← All stocks

Amneal Pharmaceuticals, Inc.

AMRX Net selling
CIK 0001723128 #1201 in the set updated 17 Sep 2026
Bought (120 mo)
$13.00M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$939.10M
$1.40M on a plan · $860.12M straight out of an exercise
Sold at will
$77.58M
45 of 56 sales
Net
−$926.11M
−$64.58M against sales at will

By person

34 insiders · 88 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
APHC Holdings, LLC entity
10% owner
$855.00M (2) scheduled
−$855.00M
0
$0.00
−100.0%
Patel Tushar Bhikhubhai
10% owner
$41.75M (1)
−$41.75M
61,341,678
$1.08B
TPG GP A, LLC entity
Former 10% Owner
$9.10M (1)
−$9.10M
12,328,767
$217.48M
−24.0%
Shah Nikita
Executive Vice President
$9.00M (11)
−$9.00M
253,390
$4.47M
Fosun International Ltd entity
10% owner
$5.94M (2)
+$5.94M
327,000
$5.77M
Konidaris Tasos
Executive Vice President & CFO
$5.55M (4)
−$5.55M
449,434
$7.93M
Daly Jason B.
EVP, Chief Legal Officer
$5.25M (7)
−$5.25M
35,171
$620.42K
BOYER ANDREW S
Executive Vice President
$372.40K (2)
$4.65M (6) scheduled
−$4.27M
193,646
$3.42M
Patel Gautam
Director
$799.57K (3)
$3.95M (9)
−$3.15M
19,424,931
$342.66M
+532.1%
Patel Chirag K.
President & Co-CEO
$1.91M (6)
+$1.91M
29,044,624
$512.35M
Patel Chintu
Co-CEO
$1.91M (6)
+$1.91M
32,523,507
$573.71M
Kiely John
Director
$44.00K (1)
$1.70M (4)
−$1.66M
200,252
$3.53M
Autor Deborah M.
Director
$1.04M (5)
−$1.04M
93,660
$1.65M
MEISTER PAUL M
Director
$970.34K (2)
+$970.34K
832,800
$14.69M
Alva Emily Peterson
Director
$712.00K (1)
−$712.00K
211,029
$3.72M
Nark Ted C
Director
$119.50K (1)
$586.00K (1)
−$466.50K
325,848
$5.75M
TERRERI PETER R
Director
$289.24K (1) scheduled
−$289.24K
82,758
$1.46M
Reasons Bryan M.
CFO
$276.66K (1)
−$276.66K
82,986
$1.46M
Bisaro Paul
Executive Chairman
$203.49K (1)
+$203.49K
29,454
$519.57K
Stewart Robert A
President and CEO
$202.64K (1)
+$202.64K
78,668
$1.39M
Bhadauria Pradeep
SVP, Chief Scientific Officer
$131.66K (2)
+$131.66K
37,500
$661.50K
+7,400%
George Jeffrey P.
Director
$99.05K (1)
+$99.05K
344,614
$6.08M
Todisco Joseph
Executive Vice President
$293.00K (2)
$254.02K (2) scheduled
+$38.98K
327,194
$5.77M
+72.5%
Patel Dipan
Member of 13D Group
26,905,073
$474.61M
Yanai Shlomo
Director
320,804
$5.66M
BUCHI J KEVIN
Director
282,520
$4.98M
−20.5%
BURR ROBERT L
Director
102,639
$1.81M
Hirt Sheldon
SVP, GC & Corp. Sec.
34,993
$617.28K
BUCHEN DAVID A
SVP, Chief Legal Officer
20,426
$360.31K
+1,943%
Vergis Janet S.
Director
18,257
$322.05K
Branning Todd P.
SVP and CFO
12,785
$225.53K
Manzano Stephen
SVP, General Counsel
10,694
$188.64K
Rama Dharmendra
Director
6,107
$107.73K
Greene Jean Selden
Director
6,107
$107.73K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Patel Gautam
16 Jun 2025
Director
Sold on a plan
94,906
$8.02
$761.15K
Patel Gautam
8 Jan 2025
Director
Sold on a plan
62,590
$8.01
$501.35K
Patel Gautam
2 Jan 2025
Director
Sold on a plan
17,410
$8.01
$139.45K

What was left out

Form 4 filings counted 308
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 8
Sales at will 45
Transactions with no price 0
Shares from compensation/vesting 609,273,495
Sales filed before the plan box existed 5
History held since 8 May 2018